Predict Your Response to Immunotherapy - Tumor Mutational Burden (TMB) Assessment

An advanced genomic test that quantifies somatic mutations within a tumor's DNA. It helps clinicians identify patients likely to benefit from immunotherapy across various cancer types, optimizing personalized oncology care.